Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.

Filiaciones

Fischer S:

Cantonal Hospital St Gallen, Department of Medical Oncology and Hematology, St. Gallen, Switzerland

Manchester Cancer Research Centre, Division of Cancer Sciences, University of Manchester, and The Christie NHS Foundation Trust, Manchester, United Kingdom

Tandstad T:

The Cancer Clinic, St Olavs University Hospital, Trondheim, Norway

SWENOTECA, Trondheim, Norway

Cohn-Cedermark G:

SWENOTECA, Trondheim, Norway

Department of Oncology-Pathology, Karolinska Institute, Stockholm, and Department of Oncology, Karolinska University Hospital, Stockholm, Sweden

Thibault C:

Department of Medical Oncology, Hôpital Européen Georges Pompidou, Paris, France

Vincenzi B:

University Campus Bio-Medico, Rome, Italy

Klingbiel D:

F Hoffmann-La Roche Ltd, Basel, Switzerland

Necchi A:

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy

Terbuch A:

Abteilung für Onkologie, Universitätsklinik für Innere Medizin, Medizinische Universität Graz, Graz, Austria

Lorch A:

Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland

Heidenreich A:

Department of Urology, Uro-Oncology, Robot-Assisted and Specialized Urologic Surgery, University Hospital Cologne, Cologne, Germany

Hentrich M:

Department of Hematology and Oncology, Red Cross Hospital, University of Munich, Munich, Germany

Wheater M:

Medical Oncology, University Hospital Southampton, Southampton, United Kingdom

Langberg CW:

SWENOTECA, Trondheim, Norway

The Cancer Centre, Oslo University Hospital, Oslo, Norway

Ståhl O:

SWENOTECA, Trondheim, Norway

Department of Oncology, Skane University Hospital, Lund, Sweden

Fankhauser CD:

University of Zürich, Zürich, Switzerland

Koutsoukos K:

National & Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece

Shamash J:

St Bartholomew's Hospital, London, United Kingdom

White J:

Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

Bokemeyer C:

Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany

Beyer J:

University Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

Gillessen S:

Cantonal Hospital St Gallen, Department of Medical Oncology and Hematology, St. Gallen, Switzerland

Manchester Cancer Research Centre, Division of Cancer Sciences, University of Manchester, and The Christie NHS Foundation Trust, Manchester, United Kingdom

University of Bern, Bern, Switzerland

Oncology Institute of Southern Switzerland, Bellinzona and Universita della Svizzera Italiana, Lugano, Switzerland